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values were extracted and multiple regression was carried out. 
Variables analysed were: cylinder angle placement related to the 
craneo-caudal patient axis, rectum volume, cylinder diameter, type of 
rectal content. 
Results: Rectum volume had a significant association (p<.0001) with 
the type of rectal content. Multiple linear regression model found 
cylinder angle position, rectal volume, type of rectal content and 
cylinder diameter as the significant variables related to high rectum 
DVH dose values analysed (table). Cylinders pointing toward rectum, 
large rectum volumes, air and contrast taking part of the rectal 
content and the use of small cylinders were related to high dose 
values. 
 
 Conclusions: Despite vaginal cuff brachytherapy is a well settled 
procedure, a little way of improvement could be achieved taking care 
of the thecnique procedure; from our results, cleaning the rectum 
prior to the procedure could be one among them. 
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Purpose/Objective: This study aimed to determine the current 
application of image-guided brachytherapy (IGBT) for patients with 
uterine cervical cancer in Japan. 
Materials and Methods: In July 2012, questionnaires were sent to 171 
Japanese centers identified as having a high-dose rate (HDR) 
brachytherapy machine. The questionnaire consisted of 28 items 
regarding current practice patterns and future plans for IGBT for 
patients with cervical cancer. 
Results: Responses were received from 144 (84%) centers. Only 2% of 
the centers used ultrasound guidance routinely for applicator 
insertion, and 24% used it occasionally. Images obtained after 
applicator insertion were orthogonal X-rays (XP) alone in 59%, XP and 
CT in 28%, XP and CT and MRI in 1%, and CT/MRI without XP in 6%. MRI 
was obtained in only 2% of the centers. 3D planning for actual 
treatment was performed in 15% of the centers, while 35% performed 
CT/MRI with the applicators in place. Reasons the remaining 20% of 
the centers did not perform 3D planning for actual treatment (use 2D 
planning data with XP alone) were: limited physician time (72%), 
limited number of staff members (48%), insufficient planning software 
(31%), unproven benefit (3%) and insufficient knowledge/training in 3D 
planning (24%). CT/MRI-compatible applicators were utilized in 22% of 
the centers where the CT/MRI were acquired. The technical details of 
IGBT were analyzed for 22 centers performing the 3D planning for 
actual treatment. Contouring of organs at risk was done for the 
rectum in the 73% of the centers, for the bladder in 68%, for the 
sigmoid colon in 45%, and for the small intestine in 41%. Regarding 
target volumes, GTV-BT was contoured in 23% of the centers, HR-CTV 
in 45%, and IR-CTV in 14%. Doses were prescribed to point A alone in 
55% of the centers, point A and HR-CTV in 41%, and HR-CTV alone in 
0%. Applicator reconstruction was performed by radiation 
technologists (RT) in 68% of the centers and radiation oncologists (RO) 
in 32%. Contouring was mainly done by the RO (95%). Dose calculation 
was done by the RO (86%) and the RT (72%). Medical physicist 
involvement in these processes was limited: 9% of the centers for 
applicator construction, 9% for contouring, and 14% for dose 
calculation. Fifty-five percent of the centers where 3D planning is 
currently withheld hope to implement it for actual treatment. 
Conclusions: Although over 1/3 of the centers obtained CT images 
after applicator insertion, the use of 3D treatment planning remains 
limited in Japan.  
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Purpose/Objective: In brachytherapy also image-guidance plays an 
important role. For GYN treatments it is standard to acquire CT 
images and preferably also MR images prior to each treatment to 
calculate the dose of the day. The dose of the complete treatment is 
calculated by adding the dose metrics of each fraction e.g. V100 for 
target and D0.1cc or D2cc for OAR. It makes the safe conservative but 
incorrect assumption that the same part of the OAR always receives 
the highest dose. The dose calculated this way often limits the 
prescription dose or the target coverage. We investigate an 
alternative method to assess the cumulative dose for a treatment 
course; the use of deformable image registration (DIR) software to 
track the deformations of the OAR due to the bladder and rectum 
filling as well as by the insertion of the applicator. 
Materials and Methods: CT images are acquired during each fraction. 
Rigid registration is preformed, followed by DIR. DIR can be either 
based only on the 3D images or partially on the 3D images and on the 
organ contours. One of the problems in the pelvic region is the lack of 
contrast between structures in CT images that makes it difficult for 
DIR based on images alone. We investigated two possible solutions: (1) 
the use of CT images combined with contours (2) the use of the CT 
image modified to artificially increase the contrast in certain 
volumes.We use two optical flow deformation algorithms in parallel: a 
morphon algorithm or a demon algorithm to match the images and a 
demons algorithm applied to distance maps computed from the 
contours. The dose matrix from day2 exported from a treatment 
planning is deformed using the calculated deformation field in our 
software. We also use in-house software to generate CT images for 
simulations studies. 
Results: The first results on dose accumulation (fig 1) are based on 
contrast-enhanced CT images or the original CT image with the 
bladder contours as constraint. The use of the contrast-enhanced 
images helps to guide the DIR more than the use of the contours as 
shown by the higher DICE indices. Even for good contour matching, a 
small local error in the deformation can have significant consequences 
for the dose distribution, resulting in our example in dose metrics 
exceeding the ones calculated using the GEC-ESTRO recommendation, 
which is unphysical. 
  
Conclusions: Using DIR based on image features and contours,we 
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calculated deformation fields that can be applied to dose matrices. 
This allows us to accumulate the dose from one brachytherapy 
fraction to the next and will provide an improved estimate of the 
total dose delivered to the OAR. It should however be kept in mind 
that without a robust validation procedure,results could be very 
wrong in view of the very high dose gradients involved.The 
development of such a procedure should consequently be a 
prerequisite to any use of the deformation for brachytherapy in the 
clinic. 
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Purpose/Objective: The MR compatible Vienna (tandem-ring) and 
Utrecht applicator (tandem-ovoids) can be used for combined 
intracavitary (IC) and interstitial (IS) brachytherapy (BT) of locally 
advanced cervical cancer, with needles inserted through holes in the 
ring or ovoids. Recently a novel titanium Rotterdam applicator 
(tandem-ovoids) (Nucletron, Elekta) has been introduced which is well 
suited for MR guided IC BT of cervical cancer. This applicator has a 
fixed geometry and therefore enables fast and accurate applicator 
reconstruction. Currently the Rotterdam applicator does not include 
holes in the ovoids for needle positioning. The configuration of the 
holes restricts the possible locations and directions of needles. 
Therefore, the holes in the ovoids should be positioned such to allow 
optimal needle positioning for every patient. The purpose of this study 
is to determine the optimal configuration of the holes for needle 
positioning in the ovoids of the Rotterdam applicator making it 
suitable for combined IC/IS BT. 
Materials and Methods: A planning study was performed using MR 
datasets of 4 randomly chosen patients receiving IC BT for cervical 
cancer using the Rotterdam applicator. HR-CTV (range 1.2 – 57.5 cc), 
IR-CTV, rectum, sigmoid and bladder were delineated. The applicator 
was reconstructed with the aid of the applicator library file, a digital 
model of the applicator, present in the treatment planning system. 
For the IC treatment, without interstitial needles, modification of the 
standard treatment plan, that prescribes 7 Gy in points A, was 
necessary for all cases in order to restrict the dose to the OARs. The 
optimal position and direction of the ovoid holes for needle 
positioning was studied by adding virtual holes to the applicator 
library file at different locations and directions. This way treatment 
plans could be optimized for different needle (hole) configurations 
aiming at an increase of the dose to the HR-CTV while limiting the 
dose to the OARs. The configuration that yielded the best results 
among the 4 patients will be used as a blueprint for the holes in a 
prototype of the new applicator. 
Results: When using the IC applicator alone without needles, the dose 
in points A needed to be reduced from 7 Gy to 4.9 - 6.7 Gy. This 
resulted in a coverage of the delineated HR-CTV of (only) 66.5, 60.0, 
82.3 and 100.0 %, respectively, with a D90 HR-CTV of 4.9, 7.0, 5.9 and 
9.8 Gy. It turned out that a geometry allowing for insertion of 
maximally 3 needles per ovoid, each having an angle of 15º with the 
tandem in ventral-dorsal direction, resulted in a considerable increase 
of the D90 HR-CTV. For this geometry the coverage of the HR-CTV was 
88.1, 99.7, 98.6 and 100.0 %, respectively. The D90 HR-CTV was 6.7, 
9.5, 9.4 and 10.2 Gy. 
Conclusions: We have studied the optimal configuration of holes in 
the ovoids of the Rotterdam applicator for needle positioning for 
combined IC/IS treatment of locally advanced cervical cancer. A 
prototype of this new applicator is being build.  
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Purpose/Objective: The effect of bladder fullness on dose-volume 
parameters of OARs during the HDR intracavitary brachytherapy 
procedure with tandem-ovoid applicators and 192Ir source have been 
studied for cervical cancer patients who had complete response after 
EBRT. 
Materials and Methods: 17 patients with various cervical cancer 
stages with good remission of tumor after treating by 45-50 Gy 
external beam (there was no sign of residual tumor in taking MRIs 
after external beam treatment) took intracavitary Brachytherapy by 
Rotterdam Tandem-Ovoids applicators undergone two set of CT scans 
consecutively, one with filling the bladder by 120cc of normal saline 
solution and 3cc Meglumin compound and the other one with making 
the bladder as empty as possible, by trying to have no intended body 
motion during acquisitions. 3D image reconstruction has been done, 
and after that HR-CTV and OARs contouring applied, on the bases of 
GEC-ESTRO recommendations, for both CT sets. Finally 3D treatment 
planning has been achieved by the optimization capability of the 
software and exertion of manual corrections for dwell positions and 
times. 
Results: The volume of full and empty bladders was 166.5±26.4 and 
61.0±18.5, respectively. Paired samples T-test (P value=0.05) was 
used and the result have been indicated that there is no significant 
difference in D (2 cc), D (0.1 cc) and D (1 cc) of bladder, and also, D 
(2 cc) and D (0.1 cc) of rectum and sigmoid (p>0.05). Although, 
getting average of these dose parameters values respect to prescribe 
dose has shown a reduction for empty bladder condition. Mean 
Percentage Difference of CTV volumes were in the range of 0.00-0.08 
for two groups of contouring the patients CTs.  
 
 Mean value (percentage of prescribed dose)  
p-
value 
Empty bladder (%) Full bladder (%)   
0.098 74.2 82.7 
D (2cc) 
Bladder 
0.535 66.9 68.2 Rectum
0.830 46.8 47.4 Sigmoid
0.098 82.1 91.5 D (1cc) Bladder




0.264 89.4 93.0 Rectum
0.514 66.5 73.3 Sigmoid
0.330 96.9 94.5 D90 CTV 
Conclusions: Bladder filling had various influence on the position of 
bladder, cervix and uterus in respect to each other, corresponding to 
the various uterine anatomies (retroversion or anteversion) and 
posture of bladder relative to surrounding organs. The few 
discrepancies in CTV volume between two planning was due to 
considering GEC-ESTRO and ICRU recommendations in contouring HR-
CTVs and movement of OARs between these two patient anatomy 
conditions. Decrease in average of dose parameters for OARs and 
Increase in D90 for empty bladders can be a good motivation to 
choose this status although statistical test couldn’t improve it. Having 
two series of CT data in empty/full condition, at least for the first 
fraction of BT, can act as guidance and give a useful vision of 
anatomical reactions in each situation, but compromising with patient 
dose. Study is in progress for more case analysis.  
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Purpose/Objective: To objectively evaluate the implementation of 
MR Image Based Brachytherapy in Cervical Cancers at our centre.  
Materials and Methods: The approach consists of reporting the 
retrospective analysis of dosimetric and clinical outcome of 24 
patients (RD experience) with prescription to point A followed by 
prospective data (PD Experience) with HR-CTV dose optimization, 
prescription and contribution to multicentric International EMBRACE 
study. The dosimetric data (EQD2 values) and clinical outcome for 
these groups were compared and evaluated further with respect to 
